Progress in Advocacy with the Children’s Cancer Cause 2021

Visit for a complete list of podcasts available, including this one.

Today’s show is a recap of recent advances in childhood cancer advocacy and reiterates the basic facts about childhood cancer for which we strive to provide a worldwide platform for awareness at Childhood Cancer Talk Radio.

As co-founder of DIPG Advocacy Group, host Janet Demeter is in a unique position to share the latests developments for childhood brain cancer advocacy and a new introduction of the National DIPG Awareness Resolution.  At half-time we are privileged to bring you some excerpts from a recent webinar with the Children’s Cancer Cause with Sue Emmer, Policy Counsel, detailing the three most important points of focus for advocacy for children with cancer as we move forward into 2021:  community collaboration, pediatric drug discovery and development, and support for childhood cancer survivors.

Children’s Cancer Cause is the leading national advocacy organization working to achieve access to less toxic and more effective pediatric cancer therapies; to expand resources for research and specialized care; and to address the unique needs and challenges of childhood cancer survivors and their families.

Children’s Cancer Cause, founded in 1999 as The Children’s Cause, Inc., was established to take a leadership role in advocacy and training on national issues affecting childhood cancer.

Children’s Cancer Cause leads efforts to ensure that these needs and perspectives of children with cancer are integrated into the highest deliberations on health care and cancer policy at the Federal level.  Please visit their website at to learn more.

Comments are closed.